Panacea Life Sciences Holdings, Inc. (PLSH) Capital expenditures 2014–2023
Panacea Life Sciences Holdings, Inc. (PLSH) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$65,322FY2023 · since FY2014: $6,018 → $65,322
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $65,322 | -73.2% |
| FY2022 | $243,804 | +49.6% |
| FY2021 | $162,946 | -94.9% |
| FY2020 | $3.2M | +491.3% |
| FY2019 | $541,203 | — |
| FY2018 | $0 | — |
| FY2016 | $1,292 | — |
| FY2015 | $0 | -100.0% |
| FY2014 | $6,018 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice